Johns Hopkins Medical Institute Acquires BioDiscovery's Nexus Expression Software for Analysis of Gene Regulation

Share Article

BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research, announced today that the Johns Hopkins Medical Institute has acquired a multi-seat license of Nexus Expression, a new intuitive and powerful tool for microarray gene expression analysis.

BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research, announced today that the Johns Hopkins Medical Institute has acquired a multi-seat license of Nexus Expression, a new intuitive and powerful tool for microarray gene expression analysis.

Dr. Chris Cheadle, Director of the Lowe Family Genomics Core at Johns Hopkins Bayview Medical Center, stated, "Nexus Gene Expression represents for us the next step in microarray data analysis software. It combines statistical rigor at the back end while allowing the user maximum flexibility at the front end allowing him/her to view any selected subset of genes in heat map form for all samples in a project with immediate data capture and annotation linkouts readily available at all stages of the analysis. In addition, Nexus provides both functional annotation and enrichment analysis, as well as gene set analysis (using a GSEA-like algorithm) in real time and also allows the user to input custom lists of genes for advanced signature analysis. We are encouraging our clients to consider the use of this tool for comprehensive microarray data mining."

Dr. Soheil Shams, President of BioDiscovery, said, "We are happy to have one of the leading research institutions adopt Nexus Expression as their preferred choice for gene expression data analysis and visualization. We have worked hard to use our decade long experience in this field to create a totally new user experience for fast, easy and accurate analysis of expression data leading to biological discoveries."

Nexus Expression is a platform independent product and supports all array platforms including Affymetrix, Agilent, Illumina, Roche NimbleGen, and custom arrays. With single mouse clicks, the user can cluster genes and samples to discover expression patterns, simultaneously compare expression profiles of multiple comparisons alongside gene annotations, display significant genes in affected biological processes, perform enrichment analysis to identify genes that are significantly overrepresented in a population, and much more. With an intuitive interface and rich graphical and numerical outputs that are publication ready, Nexus Expression is an ideal product for those performing gene expression analysis.

About BioDiscovery, Inc.
BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact us: 310-414-8100 or http://www.biodiscovery.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Soheil Shams, President & CSO
Visit website